Want real case studies? 10 seconds to sign up
Join the platform
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
December 18, 2025
Approximately 5 minutes
MDCG Guidance: Navigating the 'Best Practice' Landscape of EU MDR
Since the Medical Device Regulation (MDR 2017/745) came into force, the Medical Device Coordination Group (MDCG) has published over 70 guidance and position papers. As the regulatory landscape evolves, these documents have become essential tools for manufacturers, importers, and Notified Bodies alike.
Are MDCG Documents Law?
Technically, no. MDCG documents are not formal legislation. However, they represent the European Commission’s official interpretation of "best practice." In the eyes of the regulatory system, they serve as the gold standard for how the MDR should be applied in real-world scenarios.
Can Notified Bodies Raise Findings Based on MDCG Guidance?
The answer is a definitive Yes. According to MDR Annex VII, Section 4.5.2, Notified Bodies are required to ensure that audit findings are classified consistently with:
- The requirements of the Regulation (MDR).
- Relevant harmonized standards.
- Best practice documents developed or adopted by the MDCG.
How Findings Are Written
While a Notified Body can use MDCG guidance to justify a non-conformity, they cannot cite the guidance in isolation. A valid finding must always be linked back to a specific MDR requirement, such as Article 10 (General obligations of manufacturers) or Annex IX/XI (Conformity assessment). The MDCG document serves as the evidence of what "compliance" looks like for that specific requirement.
Why It Matters for Manufacturers
MDCG documents significantly shape the interpretation of the MDR. Staying compliant is no longer just about reading the original law; it requires:
- Continuous Monitoring: Regularly checking for new MDCG publications.
- Gap Analysis: Assessing current Quality Management Systems (QMS) against new "best practice" definitions.
- Proactive Integration: Implementing MDCG recommendations before a Notified Body audit to avoid predictable findings.
Bottom Line: MDCG documents are more than just suggestions. They are the practical roadmap to achieving and maintaining MDR certification in an increasingly complex regulatory environment.
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
Global MedTech Compliance: A Comparative Analysis of EU-MDR and UK MHRA Frameworks (2026)
An expert synthesis of the regulatory landscape in 2026, comparing the clinical-heavy requirements of EU-MDR with the pragmatic, reliance-based pathways of the UK MHRA.
Approximately 5 minutes
Master Technical Documentation under MDR 2017/745
Technical Documentation (TD) is more than just paperwork; it is the foundation of your device's identity and proof of conformity with MDR 2017/745. This article explores the 'Iceberg' of TD, breaking down the 7 essential pillars from GSPR to Post-Market Surveillance. Learn how to apply the 3Cs—Clarity, Consistency, and Connectivity—to ensure faster Notified Body reviews and a safer time to market.
Approximately 5 minutes
EUDAMED Mandatory Timeline: Essential Insights from the Brussels Workshop
With the Commission Decision 2025/2371, EUDAMED is now officially functional. The modules for Actor, Device, and Market Surveillance become mandatory on May 28, 2026. This article outlines the critical steps for manufacturers, including EU Login setup, the strict registration order, and the distinction between the Playground and Production environments.
Approximately 5 minutes
Bridging the Gap: EU vs. US Clinical Evidence Requirements for Medical Devices
Navigating the clinical evidence requirements of the EU MDR and the US FDA often catches companies off-guard. While the EU focuses on the Clinical Evaluation Report (CER) and GSPR alignment, the FDA relies on a risk-driven approach involving PMAs and 510(k) substantial equivalence. This article explores how ISO 14155 serves as a common language for both regions and highlights common weaknesses in clinical strategies that lead to regulatory rework.
Approximately 5 minutes
EU Commission to Harmonize Notified Body Procedures: Predictability in Sight
The European Commission is developing a new implementing regulation to address the unpredictability of medical device and IVD conformity assessments. Currently, significant variations in timelines and costs among Notified Bodies cause delays that impact patient care. This new law will require Notified Bodies to publish clear review timelines, define 'clock stoppers,' and provide transparent cost breakdowns for certification and surveillance activities.